Search Results - Mark Sumeray
- Showing 1 - 2 results of 2
-
1
Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine by Isabel Leroux-Roels, Jacques Bruhwyler, Lilli Stergiou, Mark Sumeray, Jasper Joye, Cathy Maes, Paul-Henri Lambert, Geert Leroux-Roels
Published in Vaccines (2023-02-01)Get full text
Article -
2
